Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.605 SEK | -3.89% | -9.07% | -26.38% |
Apr. 24 | Dignitana AB Announces Chief Executive Officer Changes , Effective May 2, 2024 | CI |
Apr. 04 | Dignitana Raises SEK19 Million via Rights Issue of Shares | MT |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- Low profitability weakens the company.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-26.38% | 10.81M | - | ||
+72.58% | 12.34B | B- | ||
-18.04% | 7.98B | C+ | ||
+5.39% | 5.81B | B | ||
+6.65% | 5.04B | D+ | ||
+20.83% | 4.31B | - | ||
-20.27% | 4.03B | B- | ||
-41.19% | 2.21B | C | ||
+0.74% | 1.99B | - | ||
+4.02% | 1.87B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- DIGN Stock
- Ratings Dignitana AB